Ovid Therapeutics
OVID
OVID
91 hedge funds and large institutions have $144M invested in Ovid Therapeutics in 2020 Q3 according to their latest regulatory filings, with 24 funds opening new positions, 22 increasing their positions, 29 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
less ownership
Funds ownership: →
11% less capital invested
Capital invested by funds: $161M → $144M (-$17.1M)
24% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 29
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Holders
91
Holding in Top 10
–
Calls
$760K
Puts
$465K
Top Buyers
| 1 | +$14.3M | |
| 2 | +$7.17M | |
| 3 | +$7.06M | |
| 4 |
SI
Sofinnova Investments
Menlo Park,
California
|
+$6.3M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$2.72M |
Top Sellers
| 1 | -$18.9M | |
| 2 | -$4.98M | |
| 3 | -$4.6M | |
| 4 |
Assenagon Asset Management
Senningerberg,
Luxembourg
|
-$3.76M |
| 5 |
BlackRock
New York
|
-$886K |